Genome Methylation Accurately Predicts Neuroendocrine Tumor Origin: An Online Tool.

Wenzel M Hackeng Koen M A DreijerinkWendy W J de LengFolkert H M Morsink Gerlof Dirk ValkMenno R VriensG Johan A OfferhausChristoph Geisenberger Lodewijk A A Brosens

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

This DNA methylation-based prediction model can be used in the workup for patients with neuroendocrine tumors of unknown primary. To facilitate validation and clinical implementation, we provide a user-friendly, publicly available web-based version of NEN-ID.

Keyphrases

neuroendocrine tumors
dna methylation
genome wide
gene expression
primary care
healthcare
copy number
psychometric properties
quality improvement
low cost